A dog walks as members of security forces are deployed during clashes with supporters of opposition leader Ousmane Sonko after his parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

Members of security forces clash with supporters of opposition leader Ousmane Sonko after his parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

Supporters of opposition leader Ousmane Sonko hurl stones during clashes with security forces after Sonko's parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

Supporters of opposition leader Ousmane Sonko react to tear gas during clashes with security forces after Sonko's parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

A supporter of opposition leader Ousmane Sonko hurls stones during clashes with security forces after Sonko's parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

Supporters of opposition leader Ousmane Sonko gather during clashes with security forces after Sonko's parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

Supporters of opposition leader Ousmane Sonko gather after his parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

Members of security forces detain a supporter of opposition leader Ousmane Sonko during clashes after Sonko's parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

Members of security forces detain a supporter of opposition leader Ousmane Sonko during clashes after Sonko's parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

Members of security forces clash with supporters of opposition leader Ousmane Sonko after his parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

People on a motorcycle react as supporters of opposition leader Ousmane Sonko clash with security forces after Sonko's parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

A supporter of opposition leader Ousmane Sonko runs during clashes with security forces after Sonko's parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

Supporters of opposition leader Ousmane Sonko gather in front of security forces during clashes after Sonko's parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

Supporters of opposition leader Ousmane Sonko hurl stones during clashes with security forces after Sonko's parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

A member of security forces fires a weapon during a clash with supporters of opposition leader Ousmane Sonko after his parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

A supporter of opposition leader Ousmane Sonko hurls stones during clashes with security forces after Sonko's parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

A supporter of opposition leader Ousmane Sonko gestures during clashes with security forces after Sonko's parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

A supporter of opposition leader Ousmane Sonko runs during clashes with security forces after Sonko's parliamentary immunity was lifted following accusation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

Memebrs of security forces clash with supporters of opposition leader Ousmane Sonko after his parliamentary immunity was lifted following accussation of sexual assault in Dakar, Senegal March 3, 2021. REUTERS/Zohra Bensemra

Actors perform on stage to an audience whose members have a "Green Pass", a pass for those vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity, at the Khan Theatre in Jerusalem February 25, 2021. Picture taken February 25, 2021. REUTERS/Ronen Zvulun

Audience members with a "Green Pass", a pass for those vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity, wear face masks as they watch a show at the Khan Theatre in Jerusalem February 25, 2021. Picture taken February 25, 2021. REUTERS/Ronen Zvulun

A woman shows her "Green Pass", a pass for those vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity, as she enters a show at the Khan Theatre in Jerusalem February 25, 2021. Picture taken February 25, 2021. REUTERS/Ronen Zvulun

A senior resident couple pose for a photo with their "Green Pass", a pass for those vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity, before they enter a live performance by Israeli singer Nurit Galron, at Yarkon park, in Tel Aviv, Israel February 24, 2021. REUTERS/Amir Cohen

A senior resident wears a mask and shows her "Green Pass", a pass for those vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity, as she enters a live performance by Israeli singer Nurit Galron, at Yarkon park, in Tel Aviv, Israel February 24, 2021. REUTERS/Amir Cohen

A drone picture shows the venue where a concert by Israeli singer Nurit Galron is taking place for people who were vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity had to show their "Green Pass" to enter, at Yarkon park, in Tel Aviv, Israel February 24, 2021. REUTERS/Amir Cohen

A senior resident wears a mask and shows his "Green Pass", a pass for those vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity, as he enters a live performance by Israeli singer Nurit Galron, at Yarkon park, in Tel Aviv, Israel February 24, 2021. REUTERS/Amir Cohen

A man wears a mask and listens to music after he had to show his "Green Pass", a pass for those vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity, to enter a live performance by Israeli singer Nurit Galron, at Yarkon park, in Tel Aviv, Israel February 24, 2021. REUTERS/Amir Cohen

Senior residents wear masks showing their "Green Pass", a pass for those vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity, as they enter a live performance by Israeli singer Nurit Galron, at Yarkon park, in Tel Aviv, Israel February 24, 2021. REUTERS/Amir Cohen

A doorman checks senior residents' "Green Pass", a pass for those vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity, before they enter a live performance by Israeli singer Nurit Galron, at Yarkon park, in Tel Aviv, Israel February 24, 2021. REUTERS/Amir Cohen

Audience wear masks and listen to music after they had to show their "Green Pass", a pass for those vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity, to enter a live performance by Israeli singer Nurit Galron, at Yarkon park, in Tel Aviv, Israel February 24, 2021. REUTERS/Amir Cohen

Audience wear masks and listen to music after they had to show their "Green Pass", a pass for those vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity, to enter a live performance by Israeli singer Nurit Galron, at Yarkon park, in Tel Aviv, Israel February 24, 2021. REUTERS/Amir Cohen

A musician plays his guitar in a concert where the audience had to show their "Green Pass", a pass for those vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity, to enter a live performance by Israeli singer Nurit Galron, at Yarkon park, in Tel Aviv, Israel February 24, 2021. REUTERS/Amir Cohen

Audience wear masks, listen to music and dance after they had to show their "Green Pass", a pass for those vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity, to enter a live performance by Israeli singer Nurit Galron, at Yarkon park, in Tel Aviv, Israel February 24, 2021. REUTERS/Amir Cohen

Audience wear masks and listen to music after they had to show their "Green Pass", a pass for those vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity, to enter a live performance by Israeli singer Nurit Galron, at Yarkon park, in Tel Aviv, Israel February 24, 2021. REUTERS/Amir Cohen

Israeli singer Nurit Galron thanks the audience during her concert where the audience had to show their "Green Pass", a pass for those vaccinated against the coronavirus disease (COVID-19) or those with presumed immunity, to enter a live performance, at Yarkon park, in Tel Aviv, Israel February 24, 2021. REUTERS/Amir Cohen

Felicisima de la Fuente, a 106-year-old resident, sits in a minibus as she leaves Asispa Las Azaleas nursing home to attend a special theatre show for residents and nursing homes workers who have achieved immunity against the coronavirus disease (COVID-19) after receiving the second dose of Pfizer-BioNTech vaccine in Madrid, Spain, February 24, 2021. REUTERS/Sergio Perez

Felicisima de la Fuente, a 106-year-old resident, and fellow resident Antonia Porro, 96, sit in a minibus as they leave Asispa Las Azaleas nursing home to attend a special theatre show for residents and nursing homes workers who have achieved immunity against the coronavirus disease (COVID-19) after receiving the second dose of Pfizer-BioNTech vaccine in Madrid, Spain, February 24, 2021. REUTERS/Sergio Perez

Felicisima de la Fuente, a 106-year-old resident, arrives at the theatre to attend a special show for residents and nursing homes workers who have achieved immunity against the coronavirus disease (COVID-19) after receiving the second dose of Pfizer-BioNTech vaccine in Madrid, Spain, February 24, 2021. REUTERS/Sergio Perez

Nursing homes residents and workers, who have achieved immunity against the coronavirus disease (COVID-19) after receiving the second dose of Pfizer-BioNTech vaccine, attend a special theatre show in Madrid, Spain, February 24, 2021. REUTERS/Sergio Perez

Felicisima de la Fuente, a 106-year-old resident, sits in a minibus as she leaves Asispa Las Azaleas nursing home to attend a special theatre show for residents and nursing homes workers, who have achieved immunity against the coronavirus disease (COVID-19) after receiving the second dose of Pfizer-BioNTech vaccine, in Madrid, Spain, February 24, 2021. REUTERS/Sergio Perez

Felicisima de la Fuente, a 106-year-old resident, applauds at the end of a special theatre show for residents and nursing homes workers who have achieved immunity against the coronavirus disease (COVID-19) after receiving the second dose of Pfizer-BioNTech vaccine, in Madrid, Spain, February 24, 2021. REUTERS/Sergio Perez

Felicisima de la Fuente, a 106-year-old resident, watches a special theatre show for residents and nursing homes workers who have achieved immunity against the coronavirus disease (COVID-19) after receiving the second dose of Pfizer-BioNTech vaccine in Madrid, Spain, February 24, 2021. REUTERS/Sergio Perez

Nursing homes residents and workers, who have achieved immunity against the coronavirus disease (COVID-19) after receiving the second dose of Pfizer-BioNTech vaccine, attend a special theatre show in Madrid, Spain, February 24, 2021. REUTERS/Sergio Perez

Nursing homes residents and workers, who have achieved immunity against the coronavirus disease (COVID-19) after receiving the second dose of Pfizer-BioNTech vaccine, attend a special theatre show in Madrid, Spain, February 24, 2021. REUTERS/Sergio Perez

Nursing homes residents and workers, who have achieved immunity against the coronavirus disease (COVID-19) after receiving the second dose of Pfizer-BioNTech vaccine, attend a special theatre show in Madrid, Spain, February 24, 2021. REUTERS/Sergio Perez

Felicisima de la Fuente, a 106-year-old resident, leaves the theatre accompanied by her granddaughter Andrea Sarria, at the end of a special show for residents and nursing homes workers who have achieved immunity against the coronavirus disease (COVID-19) after receiving the second dose of Pfizer-BioNTech vaccine in Madrid, Spain, February 24, 2021. REUTERS/Sergio Perez

Residents and nursing homes workers, who have achieved immunity against the coronavirus disease (COVID-19) after receiving the second dose of Pfizer-BioNTech vaccine, applaud during a special theatre show in Madrid, Spain, February 24, 2021. REUTERS/Sergio Perez

Felicisima de la Fuente, a 106-year-old resident, leaves the theatre accompanied by her granddaughter Andrea Sarria, at the end of a special show for residents and nursing homes workers who have achieved immunity against the coronavirus disease (COVID-19) after receiving the second dose of Pfizer-BioNTech vaccine in Madrid, Spain, February 24, 2021. REUTERS/Sergio Perez

Felicisima de la Fuente, a 106-year-old resident, sits to attend a special theatre show for residents and nursing homes workers who have achieved immunity against the coronavirus disease after receiving the second dose of Pfizer-BioNTech COVID-19 vaccine, in Madrid, Spain, February 24, 2021. REUTERS/Sergio Perez

Vials of routine vaccines for child immunization are pictured with syringes at a local health center in Manila, Philippines January 27, 2021. Picture taken January 27, 2021. REUTERS/Eloisa Lopez

Brazil's President Jair Bolsonaro and Brazil's Health Minister Eduardo Pazuello react during a ceremony to announce a mass coronavirus disease (COVID-19) immunization program, at the Planalto Palace in Brasilia, Brazil, December 16, 2020. Picture taken December 16, 2020. REUTERS/Ueslei Marcelino

Brazil's President Jair Bolsonaro and Brazil's Health Minister Eduardo Pazuello arrive for a ceremony to announce a mass coronavirus disease (COVID-19) immunization program, at the Planalto Palace in Brasilia, Brazil, December 16, 2020. Picture taken December 16, 2020. REUTERS/Ueslei Marcelino

Brazil's President Jair Bolsonaro walks near Brazil's Health Minister Eduardo Pazuello during a ceremony to announce a mass coronavirus disease (COVID-19) immunization program, at the Planalto Palace in Brasilia, Brazil, December 16, 2020. Picture taken December 16, 2020. REUTERS/Ueslei Marcelino

Brazil's Health Minister Eduardo Pazuello speaks during a ceremony to announce a mass coronavirus disease (COVID-19) immunization program, at the Planalto Palace in Brasilia, Brazil, December 16, 2020. Picture taken December 16, 2020. REUTERS/Ueslei Marcelino

Brazil's Health Minister Eduardo Pazuello reacts during a ceremony to announce a mass coronavirus disease (COVID-19) immunization program, at the Planalto Palace in Brasilia, Brazil, December 16, 2020. Picture taken December 16, 2020. REUTERS/Ueslei Marcelino

Marcie Meek, 88, poses for a photo with a sign referring to herd immunity after receiving the coronavirus disease (COVID-19) vaccine at the Brightwater Senior Living community in Highland, California, U.S., January 22, 2021. REUTERS/Lucy Nicholson

Authorities handle a package of Oxford-Astrazeneca COVID-19 vaccines at the storage of the Expanded Program on Immunization (EPI), that arrived from India as a gift to Bangladesh, in Dhaka, Bangladesh January 21, 2021. REUTERS/Mohammad Ponir Hossain

Specialists are seen at Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products, which conducts development of Russia's third vaccine against the coronavirus disease (COVID-19), in Moscow, Russia January 13, 2021. REUTERS/Maxim Shemetov

Konstantin Chernov, deputy director of Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products, which conducts development of Russia's third vaccine against the coronavirus disease (COVID-19), poses for a portait at a laboratory in Moscow, Russia January 13, 2021. REUTERS/Maxim Shemetov

Konstantin Chernov, deputy director of Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products, which conducts development of Russia's third vaccine against the coronavirus disease (COVID-19), looks at specialists at work in Moscow, Russia January 13, 2021. REUTERS/Maxim Shemetov